Sunday, October 30, 2016

PhD programmes in AYUSH

UGC asks universities to provide PhD programmes in AYUSH disciplines

  • HT Correspondent, Hindustan Times, New Delhi
  •  |  
  • Updated: Oct 28, 2016 14:57 IST
  • Students will now be able to pursue PhD in traditional medicine courses after the University Grants Commission (UGC) asked all central universities to start a doctorate degree programmes under AYUSH disciplines.
    On June 24, AYUSH ministry had written a letter to the UGC requesting it to issue an advisory to educational institutions on the same. AYUSH has announced PhD programmes in AYUSH disciplines from the concerned research council.
    The research councils in the field of Ayurvedic Sciences, Homoeopathy, Yoga and Naturopathy among others also conduct clinical and basic research studies and they want to extend research opportunities through PhD fellowship programme for the development of AYUSH.
    UGC has asked all central universities to set up a system for enrolment of candidates in the PhD programme and providing them an opportunity to avail fellowship from the concerned research council. The councils will sponsor 200 candidates: 125 postgraduate of Ayush and 75 of science and technology streams for pursuing PhD on Ayush research topics.

Friday, October 28, 2016

Ayrveda Day 28 Oct.

National Ayurveda Day to be celebrated on Dhanteras

Manoj Nesari, Advisor to the Ministry of Ayurveda said that states across the country have been informed about this decision and the theme will be ‘Ayurveda for Prevention and Control of Diabetes.’

The Indian Express
By: Express News Service | Pune | Published:October 27, 2016 3:16 am

AFTER ‘YOGA Day’, the centre has now decided to observe National Ayurveda Day. A circular issued by the AYUSH department to all states says there is a lot of ignorance about this ancient science and Dhanteras (Oct 28) will be celebrated as per the Indian tradition as National Ayurveda Day.

Manoj Nesari, Advisor to the Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), told The Indian Express that states across the country have been informed about this decision and the theme will be ‘Ayurveda for Prevention and Control of Diabetes.’

Dhanvantari is the God of Ayurveda and it is only fitting that National Ayurveda Day is observed on Dhanvantari Jayanti or Dhanteras, Nesari said. State AYUSH directorates, ayurveda educational institutions and pharmaceutical companies will commemorate the occasion by organizing public lectures, seminars and exhibitions. Health check-up camps and awareness programmes will be held on the occasion, Nesari added.
In the city, several ayurveda experts have welcomed the decision. Dr Suhas Parchure,former president of NIMA said ayurveda is an ancient Indian medicine system but ayurvedic medicine is not being sent to other countries. “We hope with the introduction of an Ayurveda Day, several issues will be taken up,” he said.

Thursday, October 13, 2016

IAS official's Ayurvedic medicines


Minister to launch IAS official's Ayurvedic medicines


Summary: Many patients have been cured by my medicines,” Raju told TOI on Sunday.After the launch, the medicines would be available on major e-commerce websites. The Ayurvedic medicines developed by me multiply good cells and prevent the growth of bad cells. Patna: Life-saving Ayurvedic medicines developed by Bihar cadre IAS official S M Raju would be officially launched by Union minister of state for Ayush Shripad Yesso Naik in New Delhi on Tuesday. “The six medicines to be launched on October 11 were issued licence from the Ministry of Ayush in June last year. The drugs are anti-ageing syrup and for ortho, cardiovascular, liver, kidney and gastro related problems.“Human body is made of cells.
Patna: Life-saving Ayurvedic medicines developed by Bihar cadre IAS official S M Raju would be officially launched by Union minister of state for Ayush Shripad Yesso Naik in New Delhi on Tuesday. The drugs are anti-ageing syrup and for ortho, cardiovascular, liver, kidney and gastro related problems.“Human body is made of cells. The Ayurvedic medicines developed by me multiply good cells and prevent the growth of bad cells. 

Many patients have been cured by my medicines,” Raju told TOI on Sunday.After the launch, the medicines would be available on major e-commerce websites. “Total 50% of the revenue to be generated by sale of my medicines would be spent on education of financially poor children in rural areas,” said Raju.An avid researcher in Ayurveda, Raju has been granted leave for two months, which is likely to be extended for another two months. “I have got good support from the state as well as central government. 
Source: http://timesofindia.indiatimes.com/city/patna/Minister-to-launch-IAS-officials-Ayurvedic-medicines/articleshow/54769395.cms

Thursday, October 6, 2016

Dept of Commerce with Ayush

Centre engages Dept of Commerce with Ayush ministry to step up export of Ayush drugs

Peethaambaran Kunnathoor, Chennai
Wednesday, October 05, 2016, 08:00 Hrs  [IST]
PharmaBizz.com
With the intention of increasing the credibility of Ayush medicines in the domestic and foreign markets, and to accelerate the export, government of India is devising new schemes by engaging Department of Commerce with the Ministry of Ayush.
 
As part of the initiative, steps would be taken to promote and get recognized the ayurvedic pharmacopoeia in major markets besides promoting WHO certification for manufacturing facilities. Similarly, the Department of Commerce will strive to simplify the procedures for revalidation of monograph by countries abroad.

To deliberate on the scheme, the joint secretary of the Department of Commerce, Sudhanshu Pandey, called a meeting of all stakeholders of the Ayush industry on September 27 in New Delhi and discussed various issues in the medicine manufacturing industry and allied sectors which pose detrimental to export business. It is learnt that the commerce ministry is directed by the Union government to take steps for exporting Ayurvedic formulations to foreign countries. Pharmaceuticals Export Promotion Council (Pharmexcil) will be the agency to provide all technical supports to the exporters.

Participating in the meeting, on behalf of the ayurvedic drug manufacturers in Kerala, Dr. S.G. Ramesh Warrier, president of AMMOI, highlighted the point that getting the API monographs recognized by as many importing countries as possible would prove to be an important step in enabling ayurvedic medicines get registered in such countries. He said Indian pharmacopoeia has included about 100 ayurvedic herbs in its latest edition.  

According to Dr. Warrier, getting WHO certification for manufacturers will, indeed, improve the global acceptance of Ayurveda medicines. However, government  should consider extending financial support to enable as many units as possible to seek WHO certification. He further pointed out that the scope of the Market Access Incentive (MAI) under the Export Promotion Scheme should be widened to include ayurvedic medicines. 

Giving emphasis to classical formulations in which the Kerala manufacturers concentrate on, the president of AMMOI, said for export purpose, a list of products with known export potential should be prepared on the basis of discussions between the major stake holders. In doing so, priority should be given to finished products rather than raw herbs and intermediates.

He wanted the government to devise a mechanism of engaging the regulators of potential importing countries in discussions to convince them that pure herbal medicines should not be treated on the same plane as synthetic chemical drugs while formulating standard parameters for product registration.

Monday, October 3, 2016

Jamia Millia Islamia Jamia Nagar, New Delhi-110025, India

Guidelines for Admission in Mahir-e-Tib (M.D.) programme in Ilmul Advia and Moalajat

1. Eligibility Criteria for Admission

A candidate seeking admission in Mahir-e-Tib (M.D.) programme in Ilmul Advia and Moalajat must have obtained at least 55% marks in B.U.M.S.
 Availability of seats                Programme Code                                               duration         Seats
                                               MU01 Mahir-e-Tib (M.D.) in Ilmul Advia           3 years         7
                                               MU02 Mahir-e-Tib (M.D.) in Moalajat               3 years         7
2. Admission Procedure The candidate shall apply online for admission to Mahir-e-Tib (M.D.) programme in Ilmul Advia and Moalajat.
The online application form is available on Jamia’s website: http://www.jmi.ac.in.
The application fee of Rs. 1000/- shall be submitted online for entrance test.
The list of candidates found eligible to appear for the Entrance Test shall be notified on the website of the university.
 The candidates will have to submit an affidavit making a self-declaration for his/her availability and successful completion of the course as and when conducted by the concerned Department/Centre/Faculty. No further relaxation will be given in this respect.
Jamia Millia Islamia shall conduct entrance test for admission to the above programme followed by counseling. The M.D. programme will be managed between JMI, New Delhi and CRIUM, Hyderabad with enrollment in JMI. The CCRUM through CRIUM, Hyderabad, however, shall provide all the necessary facilities in respect of infrastructure such as Hospitals, Laboratories and other resources.
 JMI shall conduct examination in consonance with the regulations of Central Council of Indian Medicine (CCIM) and JMI besides broader framework and guidelines of Ministry of AYUSH and award the degree accordingly.
The stipend for students enrolled in Mahir-e-Tib (M.D.) programme shall by paid by CCRUM as per their norms.
 3. Entrance Test: The Entrance Test will be conducted for short-listing of the applicants. The short listed candidates will be called for counseling. The medium of Entrance Test shall be English/Urdu.
The Entrance Test for Mahir-e-Tib (M.D.) programme in Ilmul Advia and Moalajat shall include a entrance paper having 100 multiple choice (objective type) questions of one mark each of two hours duration. The admission shall be given strictly on the basis of their merit in the entrance test. The Entrance Test will be based on the Syllabus of B.U.M.S. prescribed by CCIM.
 Fee structure to Mahir-e-Tib (M.D.) candidates
                                                        Details of Fees
                                                                 1st yr              2nd yr                      3rd yr
                                                   Total      29860             26560                      26560
4. Reservation Reservation Policy will be applicable as per JMI rule.
Candidates shall submit the following documents at the time of admission to the Mahire-Tib (M.D.) Programme:
(a) Photograph of the candidate;
(b) Proof of Permanent Residential Address;
(c) Self-Attested copy of Matriculation (Class X)/equivalent for verification of date of birth;
(d) Self-Attested copy of Graduation Degree;
(e) Self-Attested copy of B.U.M.S. Mark Sheets having proof of obtaining at least 55% marks in aggregate; (f) Category Certificate;
(g) Character Certificate (in original), not more than 6 months old. In case the period extends more than 6 months then the candidate should submit a declaration certificate with respect to the intervening period, if any, after completing the qualifying course including the statement of character on a Non-Judicial Stamp Paper of Rs. 10/- duly attested by the Notary Public or Oath Commissioner;
(h) Migration Certificate (in original) must be provided within one month of the date of completion of admission, failing which admission is liable to be cancelled;
(i) No Objection Certificate from the employer, if employed (in original);
(j) If the candidate is unemployed, an Undertaking on Non-Judicial Stamp Paper of Rs. 10/- duly attested by Notary Public or Oath Commissioner.


chrome-extension://mhjfbmdgcfjbbpaeojofohoefgiehjai/index.html

not give homeopathic teething tablets

Alert on homeo baby pills

The Telegraph
Calcutta India
Sunday , October 2 , 2016 |
New Delhi, Oct. 1: The US Food and Drug Administration has cautioned that homeopathic teething tablets and gels may pose a risk to infants and young children and recommended that consumers stop using these products.
In a statement yesterday, the FDA said it had analyzed adverse events, including reports of seizures, in infants and children who had been given these products since the start of a safety alert issued in October 2010.
The agency did not say how many adverse events it had documented but merely that it was "currently investigating this issue, including testing more product samples".
Senior officials in India's Central Council of Research in Homeopathy (CCRH) said that while they did not know the background of the FDA advisory, expert panels in India had recommended the use of homeopathy for young children for ailments including teething troubles.
The FDA has said that consumers should seek medical care immediately if their child experiences seizures, difficulty in breathing, lethargy, excessive sleepiness, muscle weakness, skin flushing, constipation or difficulty in urinating after using homeopathic teething tablets or gels.
"Teething can be managed without prescription or over-the-counter remedies," Janet Woodstock, director of the FDA's center for drug evaluation and research, said in the media statement.

"We recommend parents and caregivers not give homeopathic teething tablets and gels to children and seek advice from their health care professionals for safe alternatives."

Homeopathic teething tablets or gels have not been evaluated or approved by the FDA for safety or efficacy.
"The agency is also not aware of any proven health benefit of the products which are labeled to relieve teething symptoms in children," the FDA said.
In October 2010, the FDA had issued a safety alert informing consumers that it had received reports of serious adverse events in children taking a product sold in the US for teething and found to contain belladonna, a plant-derived substance used in homeopathy. The FDA said the adverse events "were consistent with belladonna toxicity".
But senior CCRH officials said they did not know of any evidence of toxicity in children caused by homeopathic tablets.
"We believe homeopathic teething medicines are safe for use in children," Anil Khurana, research coordinator at the CCRH, told The Telegraph.
The Indian government views homeopathy as one stream of traditional medicine, similar to ayurveda, unani and siddha, and supports research on and the use of homeopathy.
The Union ministry for ayurveda, yoga, unani, siddha and homeopathy (ayush) has approved a government-supported programme called "homeopathy for a healthy child" that encourages the use of homeopathic medicines for various ailments, including teething troubles.
Another senior CCRH official said that homeopathic medicines contained active substances diluted to such low levels of concentration that they were virtually undetectable in the medicines and did not have any capacity to cause toxicity.
"It is contradictory to claim homeopathic medicines will cause toxicity," said Bindu Sharma, a qualified homeopathic doctor and member of the CCRH.
"Homeopathy has been criticized as having only a placebo effect because the medicines are so dilute. If something is so dilute that it does not exist there, how can it cause toxicity - there is a contradiction here," she said.
About 12,000 graduates and 1,200 postgraduates emerge every year from India's 195 recognized homeopathic medical colleges.
"We estimate the country has 2.7 lakh homeopathic practitioners," said Ramjee Singh, president of the Central Council of Homeopathy.